BioCentury | Dec 2, 2020
Distillery Therapeutics
Blocking PCSK9 alone or with anti-PD-1 therapies for cancer
...evaluate anti-PCSK9 therapies in combination with checkpoint inhibitors in patients.Amgen Inc. (NASDAQ:AMGN), Astellas Pharma Inc. (Tokyo:4503) and Dr. Reddy's Laboratories...